Mutation profiling by targeted sequencing of "triple-negative" essential thrombocythaemia patients

Br J Haematol. 2018 Jun;181(6):857-860. doi: 10.1111/bjh.14723. Epub 2017 May 3.

Authors

Mankai Ju¹, Rongfeng Fu¹, Huiyuan Li¹, Xiaofan Liu¹, Feng Xue¹, Yunfei Chen¹, Wei Liu¹, Yueting Huang¹, Liyan Zhang¹, Renchi Yang¹, Lei Zhang¹

Affiliation

¹ The State Key Laboratory of Experimental Haematology, Institute of Haematology and Hospital of Blood Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

PMID: 28466600
DOI: 10.1111/bjh.14723

No abstract available

Keywords: essential thrombocythaemia; mutation; myeloproliferative disorder; next-generation sequencing; triple-negative.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

DNA Mutational Analysis
Female
High-Throughput Nucleotide Sequencing*
Humans
Male
Mutation*
Thrombocythemia, Essential / genetics*